XOMA Corporation

(XOMA) Trade

By |

Profile

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. Its proprietary product candidates are X358, X213, X129, and Gevokizumab. The business operations of the company are functioned through the United States, Europe, and Asia Pacific. XOMA's primary source of revenue is from license and collaboration arrangements, contract services, and royalties.

Contact Information

Website: www.xoma.com
Email: jsnowden@oratoriumgroup.com
Main Phone: +1 510 204-7200
Address: 2200 Powell Street
Address 2: Suite 310
State: CA
City / Town: Emeryville
Country: USA
Postal Code: 94608

Issuer Information

Exchange: NSD
CEO: James R. Neal
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.23 $ -0.2 (-1.39%)
Last Price 14.23 Change $ -0.2 Change % -1.39 Tick N/A
Bid 13.51 Bid Size 100.00 Ask 17.00 Ask Size 200.00
Open 14.43 High 14.98 Low 13.95 Prev Close 14.43
Last Trade Volume 113,979 52 Wk Hi 37.25 52 Wk Low 11.88
Market Cap 119.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,395,289.00 EPS (TTM) -1.39 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 30
Number of Buys 4 10
Number of Sells 4 20
Net Activity 0 0
Last 10 Buys Shares
Fred Kurland 1,000
Last 10 Sell Shares
James R. Neal 1,000
Thomas Burns 1,000
James R. Neal 1,000
Thomas Burns 1,000
James R. Neal 1,000
James R. Neal 1,000
Thomas Burns 1,000
Thomas Burns 1,000
James R. Neal 1,000
James R. Neal 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 49 49 49 49
Low Target Price Estimate 33 33 33 33
Mean Target Price Estimate 41 41 41 41
Standard Deviation 11.31 11.31 11.31 11.31
Date of Most Recent Estimate 05/21/18 05/21/18 05/21/18 05/21/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.67